Mathias Schmidt
Director/Board Member at JCR PHARMACEUTICALS CO., LTD.
Network origin in Mathias Schmidt first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.
10
| Subsidiary | Hospital/Nursing Management | 10 |
JCR USA, Inc.
1
| Joint Venture | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mathias Schmidt via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | General Counsel | |
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNOGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
GlaxoSmithKline KK
 GlaxoSmithKline KK Household/Personal CareConsumer Non-Durables GlaxoSmithKline KK researches, develops, imports, manufactures and sells toiletry products. The company was founded on August 18, 1928 and is headquartered in Tokyo, Japan | Household/Personal Care | President Comptroller/Controller/Auditor | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Director/Board Member | |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Medical Specialties | Director/Board Member | |
Venatorx Pharmaceuticals, Inc.
 Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Director/Board Member | |
| TOTETSU KOGYO CO., LTD. | Engineering & Construction | Director/Board Member | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Analyst | |
| University of Utah | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| The College of New Jersey | College/University | Undergraduate Degree | |
| Colorado State University | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of San Diego | College/University | Masters Business Admin | |
| University of Portsmouth | College/University | Undergraduate Degree | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Future Brain KK
 Future Brain KK Investment Banks/BrokersFinance Future Brain KK is a Japanese company that engages in securities dealing and real estate management business. The company is based in Tokyo, Japan. | Investment Banks/Brokers | President | |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | General Counsel | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California | College/University | Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin | |
New York Pharma Forum, Inc.
 New York Pharma Forum, Inc. Information Technology ServicesTechnology Services New York Pharma Forum, Inc. provides information technology services for the healthcare industry. The private company is based in New York, NY. | Information Technology Services | Director/Board Member | |
| Hebei Jie Xi Bio-Products Co. Ltd. | Chairman | ||
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Japan Vaccine Co., Ltd.
 Japan Vaccine Co., Ltd. BiotechnologyHealth Technology Japan Vaccine Co., Ltd. develops and markets preventive vaccines. The joint venture company is based in Tokyo, Japan. | Biotechnology | President | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Abexxa Biologics, Inc.
 Abexxa Biologics, Inc. Pharmaceuticals: MajorHealth Technology AbeXXa Biologics, Inc. is engaged in biopharmaceutical services. The company was founded by Jon Weidanz and Debra Weidanz in 2015 and is headquartered in Arlington, TX. | Pharmaceuticals: Major | Director/Board Member | |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Pharmaceuticals: Major | Director/Board Member | |
| Pancreas Research Foundation of Japan | Chairman | ||
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 37 |
| Japan | 7 |
| United Kingdom | 3 |
| Ireland | 2 |
| Argentina | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 13 |
| Finance | 7 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 50 |
| Corporate Officer/Principal | 31 |
| Comptroller/Controller/Auditor | 17 |
| Director of Finance/CFO | 11 |
| Independent Dir/Board Member | 10 |
Most connected contacts
| Insiders | |
|---|---|
| Linda Rubinstein | 16 |
| Blaine McKee | 13 |
| Jayson Punwani | 12 |
| Richard Rychlik | 11 |
| Toshihide Yoda | 10 |
| Philippe Fauchet | 9 |
| Martin Heidecker | 9 |
| Jim Callaway | 8 |
| Derek Kelaita | 6 |
| Douglas Hunt | 5 |
| William M. Pardridge | 4 |
| Ruben J. Boado | 3 |
| Yutaka Atomi | 3 |
| Toshihiro Ishikiriyama | 3 |
| Hiroyuki Sonoda | 2 |
- Stock Market
- Insiders
- Mathias Schmidt
- Company connections
